MAPT and early-onset autosomal dominant Alzheimer disease: In the development of Alzheimer’s disease, elevated hyperphosphorylated tau and its deposition is a better indication of disease progression and has a stronger relationship with a decline in cognition than Aβ42 or Aβ40 [122,123].